Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2026-01-01 @ 4:33 PM
Study NCT ID:
NCT00368992
Status:
COMPLETED
Last Update Posted:
2015-09-14
First Post:
2006-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adenocarcinoma of the Lung | View |
| None | Adenosquamous Cell Lung Cancer | View |
| None | Bronchoalveolar Cell Lung Cancer | View |
| None | Large Cell Lung Cancer | View |
| None | Recurrent Non-small Cell Lung Cancer | View |
| None | Squamous Cell Lung Cancer | View |
| None | Stage IIIB Non-small Cell Lung Cancer | View |
| None | Stage IV Non-small Cell Lung Cancer | View |
Keywords: